Archive for Tag: pfizer news

Pfizer Inc

Pfizer vaccine for children under 5 may be available in U.S. by end-Feb

Pfizer Inc (NYSE: PFE) is trading down 3.02% at 52.69 Pfizer Inc (NYSE: PFE) and Germany’s BioNTech SE (NASDAQ: BNTX) are expected to submit an emergency use authorization request as early as Tuesday to the U.S. Food and Drug Administration (FDA) for vaccines for children aged six months to 5...

Read More

Pfizer files for U.S. authorization of promising COVID-19 antiviral pill

Pfizer Inc (NYSE:PFE) is trading down 0.10% at 49.60 Pfizer Inc (NYSE:PFE)said on Tuesday it is seeking U.S. authorization of its experimental antiviral COVID-19 pill that cut the chance of hospitalization or death for adults at risk of severe disease by 89% in a clinical trial. Pfizer said it...

Read More

Pfizer on track for U.S. vaccine boosters, Moderna lagging, Fauci says

Pfizer (NYSE:PFE) is trading flat at 46.84 Top U.S. infectious disease expert Rd. Anthony Fauci said on Sunday that officials were likely to soon get the regulatory go-ahead to administer COVID-19 vaccine booster shots made byPfizer(NYSE:PFE), althoughModerna(NASDAQ:MRNA) booster could take a little longer. Asked on CBS’ “Face the Nation,”...

Read More

Pfizer seeks U.S. approval for COVID vaccine booster

Pfizer (NYSE:PFE)is trading up 0.24% at 47.50 Pfizer Inc on Wednesday said a booster dose of its two-shot COVID-19 vaccine spurs a more than threefold increase in antibodies against the coronavirus, as the company seeks U.S. regulatory approval for a third injection. The drugmaker and its German partner BioNTech...

Read More

Israel examining heart inflammation cases in people who received Pfizer COVID shot

Pfizer (NYSE:PFE) UP 0.05% AT 38.66 Israel’s Health Ministry said on Sunday it is examining a small number of cases of heart inflammation in people who had received Pfizer (NYSE:PFE)’s COVID-19 vaccine, though it has not yet drawn any conclusions. Pfizer said it has not observed a higher rate...

Read More